Abstract: A medical device operation training apparatus, used in performing training for operation of a medical device, includes: an affected-area simulated organ holding unit configured to hold a sheet-like affected-area simulated organ able to be incised or excised at least in part; and a path simulated organ holding unit configured to hold a path simulated organ for guiding the medical device to the affected-area simulated organ. With this apparatus, trainees can train for various manipulations with simple preparatory operations.

Abstract: Porous silica-alumina particles in which pores with relatively large diameters are present at a high ratio with respect to the total pore volume, and the particles contain crystalline boehmite alumina, are disclosed. The crystalline boehmite alumina-containing porous silica-alumina particles are such that a specific surface area SA measured by the BET method is in a range of 400 to 600 m2/g, a pore volume PV measured by the BJH method is in a range of 1.0 to 2.2 ml/g, a ratio P10 of a pore volume of pores having pore diameters PD of 10 nm or larger to the total pore volume PV is in a range of 60% or higher, the pore volume of pores having pore diameters of 10 nm or larger being measured by the BJH method, and a mass ratio S/A between silica and alumina is in a range of 2/98 to 70/30.

Abstract: A production method comprises the steps of obtaining a mixed slurry by adding an alumina component and at least one selected from an alumina component and a clay mineral to a binder containing a silicon oxide; obtaining a metal trapping precursor by mixing the mixed slurry with a compound of a first metal component and heating the mixed slurry of metal component; and obtaining a metal trapping by drying and calcining the metal trapping precursor. A metal trapping comprises: a binder mainly containing silicon oxide, one or two selected from an alumina component and a clay mineral, and an oxide of a first metal component; having no peak of silicate of the first metal component detected in X-ray diffraction analysis, having an attrition resistance index CAI within a predetermined range. A fluid catalytic cracking catalyst comprises the metal trapping, a zeolite component, a binder component, and a clay mineral component.

Abstract: A silica-alumina powder, a method for producing the same, and a fluid catalytic cracking catalyst including this silica-alumina powder are provided. The silica-alumina powder contains SiO2 within a predetermined range, has a specific surface area within a predetermined range, and has a pore volume and an acid amount within predetermined ranges. An alumina raw material includes one of boehmite, pseudo-boehmite, and mainly amorphous alumina gel. The method for producing the silica-alumina powder includes a step of mixing an aqueous solution including alumina hydrate and an aqueous solution containing a silica precursor to prepare an aqueous solution including a silica-alumina precursor; a step of adjusting the pH of the aqueous solution to be within a predetermined range, and then heat-treating the aqueous solution; and a step of cooling the aqueous solution or silica-alumina slurry, then separating and washing a solid, and then drying or further calcining the solid.

Abstract: A fluid catalytic cracking catalyst for hydrocarbon oil that is a blend of two types of fluid catalytic cracking catalysts each of which has a different hydrogen transfer reaction activity or has a pore distribution within a specific range after being pseudo-equilibrated. One catalyst is a catalyst containing a zeolite and matrix components, and the other catalyst is a catalyst containing a zeolite and matrix components. This catalyst is composed of the one catalyst and the other catalyst blended at a mass ratio within a range of 10:90 to 90:10.

Abstract: A medical device operation training apparatus, used in performing training for operation of a medical device, includes: an affected-area simulated organ holding unit configured to hold a sheet-like affected-area simulated organ able to be incised or excised at least in part; and a path simulated organ holding unit configured to hold a path simulated organ for guiding the medical device to the affected-area simulated organ. With this apparatus, trainees can train for various manipulations with simple preparatory operations.

Abstract: A photodynamic therapy treatment support device is provided with a light source and a distribution information output unit. The light source irradiates a photosensitive substance administered to a body of a subject with light of a specific wavelength bandwidth having energy capable of generating fluorescence from the photosensitive substance without advancing necroses of tumor cells. The distribution information output unit outputs information on a distribution state of the fluorescence generated from the photosensitive substance, based on the fluorescence generated from the photosensitive substance.

Abstract: A production method comprises the steps of obtaining a mixed slurry by adding an alumina component and at least one selected from an alumina component and a clay mineral to a binder containing a silicon oxide; obtaining a metal trapping precursor by mixing the mixed slurry with a compound of a first metal component and heating the mixed slurry of metal component; and obtaining a metal trapping by drying and calcining the metal trapping precursor. A metal trapping comprises: a binder mainly containing silicon oxide, one or two selected from an alumina component and a clay mineral, and an oxide of a first metal component; having no peak of silicate of the first metal component detected in X-ray diffraction analysis, having an attrition resistance index CAI within a predetermined range. A fluid catalytic cracking catalyst comprises the metal trapping, a zeolite component, a binder component, and a clay mineral component.

Abstract: A fluid catalytic cracking catalyst for hydrocarbon oil that is a blend of two types of fluid catalytic cracking catalysts each of which has a different hydrogen transfer reaction activity or has a pore distribution within a specific range after being pseudo-equilibrated. One catalyst is a catalyst containing a zeolite and matrix components, and the other catalyst is a catalyst containing a zeolite and matrix components. This catalyst is composed of the one catalyst and the other catalyst blended at a mass ratio within a range of 10:90 to 90:10.

Abstract: An aluminum phosphate-modified metal-supported crystalline silicoaluminophosphate NOx-reducing catalyst includes metal-supported crystalline silicoaluminophosphate particles having a surface modified with aluminum phosphate.

Abstract: An aluminum phosphate-modified metal-supported crystalline silicoaluminophosphate NOx-reducing catalyst includes metal-supported crystalline silicoaluminophosphate particles having a surface modified with aluminum phosphate.

Abstract: Disclosed is a metal-supported catalyst produced by (a) preparing a dispersion of crystalline silicoaluminophosphate particles; (b) mixing an aqueous active ingredient metal compound solution into the dispersion; (c) spray-drying the mixture; (d) washing the spray-dried product and (e) heat-treating (calcining) the washed product at 400 to 900° C. Also disclosed is an aluminum phosphate-modified metal-supported crystalline silicoaluminophosphate catalyst having a content of aluminum phosphate in the catalyst of 0.1 to 40% by weight in terms of Al2O3+P2O5 based on the metal-supported crystalline silicoaluminophosphate particles.